Japan's PMDA completes inspection at Lupin’s Mandideep facility

04 Jun 2019 Evaluate

The Pharmaceutical and Medical Devices Agency (PMDA), Japan has completed the Good Manufacturing Practices (GMP) inspection at Lupin’s Mandideep facility (Unit-2). The inspection was conducted between May 14, 2019 and May 17, 2019. The PMDA inspection closed with no critical or major observations.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2176.25 -18.75 (-0.85%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×